Ironwood Pharmaceuticals (IRWD) Amortizatization of Intangibles (2010 - 2026)
Ironwood Pharmaceuticals' (IRWD) quarterly Amortizatization of Intangibles came in at $444000.0 in Q1 2026, up 8.56% year-on-year from $409000.0 in Q1 2025, and up 2.07% quarter-over-quarter from $435000.0 in Q4 2025.
Ironwood Pharmaceuticals (IRWD) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has disclosed Amortizatization of Intangibles across 12 years of filings, most recently posting $444000.0 for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $444000.0, up 8.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (up 8.43% YoY), and the FY2025 annual result was $1.7 million, up 8.34% from the prior year.
- Amortizatization of Intangibles came in at $444000.0 for Q1 2026 at Ironwood Pharmaceuticals, up from $435000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $444000.0 in Q1 2026 to a low of $378000.0 in Q1 2024.
- The 3-year median for Amortizatization of Intangibles is $409000.0 (2025), against an average of $410000.0.
- Peak annual rise in Amortizatization of Intangibles reached 8.57% in 2025, while the deepest fall reached 8.2% in 2025.
- Ironwood Pharmaceuticals' Amortizatization of Intangibles stood at $402000.0 in 2024, then rose by 8.21% to $435000.0 in 2025, then gained by 2.07% to $444000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $444000.0 (Q1 2026), $435000.0 (Q4 2025), and $426000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Ironwood Pharmaceuticals | 546.74 Mn | 326.27 Mn | - | 444,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 444,000.00 |
| Mar 31, 2026 | 444,000.00 |
| Dec 31, 2025 | 435,000.00 |
| Dec 31, 2025 | 435,000.00 |
| Sep 30, 2025 | 426,000.00 |
| Sep 30, 2025 | 426,000.00 |
| Jun 30, 2025 | 418,000.00 |
| Jun 30, 2025 | 418,000.00 |
| Mar 31, 2025 | 409,000.00 |
| Mar 31, 2025 | 409,000.00 |
| Dec 31, 2024 | 402,000.00 |
| Dec 31, 2024 | 402,000.00 |
| Sep 30, 2024 | 393,000.00 |
| Sep 30, 2024 | 393,000.00 |
| Jun 30, 2024 | 385,000.00 |
| Jun 30, 2024 | 385,000.00 |
| Mar 31, 2024 | 378,000.00 |
| Mar 31, 2024 | 378,000.00 |
| Dec 31, 2018 | 8,000.00 |
| Dec 31, 2018 | 8,000.00 |